Syntaxin 6‐mediated exosome secretion regulates enzalutamide resistance in prostate cancer
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Prostate cancer (PCa) deaths are typically the result of metastatic castration‐resistant PCa (mCRPC). Recently, enzalutamide (Enz), an oral androgen receptor inhibitor, was approved for treating patients with mCRPC. Invariably, all PCa patients eventually develop resistance against Enz. Therefore, novel strategies aimed at overcoming Enz resistance are needed to improve the survival of PCa patients. The role of exosomes in drug resistance has not been fully elucidated in PCa. Therefore, we set out to better understand the exosome's role in the mechanism underlying Enz‐resistant PCa. Results showed that Enz‐resistant PCa cells (C4‐2B, CWR‐R1, and LNCaP) secreted significantly higher amounts of exosomes (2‐4 folds) compared to Enz‐sensitive counterparts. Inhibition of exosome biogenesis in resistant cells by GW4869 and dimethyl amiloride strongly decreased their cell viability. Mechanistic studies revealed upregulation of syntaxin 6 as well as its increased colocalization with CD63 in Enz‐resistant PCa cells compared to Enz‐sensitive cells. Syntaxin 6 knockdown by specific small interfering RNAs in Enz‐resistant PCa cells (C4‐2B and CWR‐R1) resulted in reduced cell number and increased cell death in the presence of Enz. Furthermore, syntaxin 6 knockdown significantly reduced the exosome secretion in both Enz‐resistant C4‐2B and CWR‐R1 cells. The Cancer Genome Atlas analysis showed increased syntaxin 6 expressions associated with higher Gleason score and decreased progression‐free survival in PCa patients. Importantly, IHC analysis showed higher syntaxin 6 expression in cancer tissues from Enz‐treated patients compared to Enz naïve patients. Overall, syntaxin 6 plays an important role in the secretion of exosomes and increased survival of Enz‐resistant PCa cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
AR-V7 and Resistance to Enzalutamide and Abiraterone in Prostate Cancer
Antonarakis, E. S., Lu, C., Wang, H., Luber, B., Nakazawa, M., Roeser, J. C., Chen, Y., Mohammad, T. A., Chen, Y., Fedor, H. L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1315815 · Cited by 2,710
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278 · cited 9×
“Enz‐resistant PCa cells also develop cross‐ resistance to abiraterone, an androgen synthesis inhibitor approved to treat metastatic hormone‐refractory PCa.7 At present, Enz‐ resistant hormone‐refractory PCa is a major clinical challenge, and novel strategies aimed at overcoming Enz resistance are urgently needed to im…”
InfluentialAmnion-Epithelial-Cell-Derived Exosomes Demonstrate Physiologic State of Cell under Oxidative Stress
Sheller, S., Papaconstantinou, J., Urrabaz-Garza, R., Richardson, L., Saade, G., Salomon, C., & Menon, R. (2016) · PLOS ONE · doi:10.1371/journal.pone.0157614 · Cited by 121 · cited 1×
“For example, exosomes secreted by cells in response to oxidative stress were loaded with unique proteins representative of oxidative physiological state.(15,17,18) Thus, for this reason, exosomes are being extensively studied for the diagnosis and prognosis of several diseases, including cancer, diabetes, and atherosc…”
Cited by
The Machinery of Exosomes: Biogenesis, Release, and Uptake
Krylova, S. V., & Feng, D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021337 · Cited by 678
Exosome biogenesis: machinery, regulation, and therapeutic implications in cancer
Han, Q.-F., Li, W.-J., Hu, K.-S., Gao, J., Zhai, W.-L., Yang, J.-H., & Zhang, S.-J. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01671-0 · Cited by 678
Xu, M., Ji, J., Jin, D., Wu, Y., Wu, T., Lin, R., Zhu, S., Jiang, F., Ji, Y., Bao, B., et al. (2023) · Genes & Diseases · doi:10.1016/j.gendis.2022.03.021 · Cited by 274
Cappelletti, P., Filareti, M., Masuelli, L., Bei, R., Hassanzadeh, K., Corbo, M., & Feligioni, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-18719-2 · Cited by 12
Metadata
- Authors
- Peak, T. C., Panigrahi, G. K., Praharaj, P. P., Su, Y., Shi, L., Chyr, J., Rivera‐Chávez, J., Flores‐Bocanegra, L., Singh, R., Vander Griend, D. J., Oberlies, N. H., Kerr, B. A., Hemal, A., Bitting, R. L., & Deep, G.
- Venue
- Molecular Carcinogenesis
- Publisher
- Wiley
- Published
- 2019-11
- Volume
- 59
- Issue
- 1
- Pages
- 62-72
- ISSN
- 0899-1987 (ISSN-L)
- 1098-2744
- OpenAlex
- W2982735261
- Cited by
- 74
- References
- 3
- FWCI
- 2.01
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.